The Code of Conduct Edition 19 is being reviewed in 2024.

The purpose of the 2024 Code Review is to ensure the Code remains relevant, coherent, useful, and credible to members, the wider industry, and external stakeholders.

Reviewing Code Edition 19 will build on the work undertaken by the last Code Review. The shift towards a principles-based Code has been welcomed by members and this Review provides an opportunity to take stock of the Code and make improvements should they be identified.

Consultation is now open – feedback welcome prior to 2nd May 2024.

This consultation period opens Tuesday April 2nd 2024, and closes on Thursday, May 2nd 2024.

Feedback is welcomed from a wide variety of stakeholders, from individuals as well as companies, and anonymous feedback will be accepted.

This Consultation Paper explains the objectives, review timeframe and methodology of the review. It also highlights seven key topics to which we welcome comments. These are topics where our stakeholders are likely to have a view and are worthy of discussion. Please note that these are not the only topics that will be considered as part of the Code review.

How to provide feedback?

• • After reading the Consultation Paper, please submit your feedback via this online form.
• • You may view this form in one glance, and also save and continue if you choose to finish it at a later stage. The amount of time it will take will depend on how much feedback you have to provide.
• • If this is not your preferred method, we also accept any written feedback to the Code Help Desk.

An overview of the review process and timeline.

The Code Review is a consultative process involving Medicines Australia’s decision-making bodies, the Code Compliance Network, the patient community, members, and external stakeholders.

Expert guidance is being provided by a Code Review Working Group made up of members.

Should the review find any updates are needed, they will be put forward for formal adoption by special resolution at the Medicines Australia Annual General Meeting in October 2024. 

Please get in touch with the MA Ethics & Compliance Team if you have any questions via email or (02) 6147 6500.